纳米技术支持健康产品的监管途径和指导方针:对欧盟和美国框架的比较审查
Francisco D Rodríguez-Gómez1,2, Dominique Monferrer1,3, Oriol Penon1
1Asphalion SL, Barcelona, Spain.
Frontiers in medicine
|March 20, 2025
概括
纳米技术支持的健康产品 (NHPs) 提供了医学突破,但面临着复杂的法规. 本审查审查了欧盟和美国的指导方针,以简化NHP市场准入.
科学领域:
- 纳米医学是一种纳米医学.
- 生物技术是生物技术.
- 监管科学 监管科学
背景情况:
- 在医疗保健纳米技术的整合导致了纳米技术支持的健康产品 (NHPs).
- 国民健康计划有望在医疗治疗和诊断方面取得重大进展.
- 当前的监管框架对NHP临床应用提出了挑战.
研究的目的:
- 剖析欧盟和美国NHP的监管格局.
- 确定适用于NHPs的监管要求.
- 概述目前的监管准则,以满足人们的期望.
主要方法:
- 审查现有的监管文件和指导方针.
- 欧盟和美国对NHPs的监管方法的比较分析.
- 确定关键的监管障碍和途径.
主要成果:
- 详细概述欧盟和美国对NHP的监管要求.
- 确定与NHP开发和批准相关的具体指南.
- 分析在监管途径上导航的常见挑战.
结论:
- 了解监管环境对于成功的NHP商业化至关重要.
- 协调和澄清法规可以加速NHP的采用.
- 建议NHP开发人员积极参与监管机构.
更多相关视频
07:47Experimental Protocol to Investigate Particle Aerosolization of a Product Under Abrasion and Under Environmental Weathering
Published on: September 16, 2016
7.3K
08:47Experimental Quantification of Interactions Between Drug Delivery Systems and Cells In Vitro: A Guide for Preclinical Nanomedicine Evaluation
Published on: September 28, 2022
1.8K
相关概念视频
Drug Regulation
1.3K
Drug regulation encompasses the management of drug usage by evaluating its safety and efficacy through assessments conducted by regulatory authorities. Regrettably, the history of drug regulation is marred by several catastrophic events. One such incident is the Elixir Sulfanilamide tragedy, in which the toxic compound diethyl glycol was included in a sweet-tasting medication, leading to numerous fatalities. This event prompted the enactment of the Food, Drug, and Cosmetic Act in 1938. Under...
1.3K
Drug Control Governance: Regulatory Bodies and Their Impact
133
Drug control governance involves the oversight and regulation of pharmaceuticals to ensure their safety and efficacy while preventing illegal drug use and trafficking. Regulatory bodies, including the US Food and Drug Administration (FDA) and the European Union's European Medicines Agency (EMA), play a central role in this process. These agencies evaluate the safety and efficacy of drugs before they can be marketed. They fund clinical trials and assess the benefits and risks associated with...
133
Preclinical Development: Overview
4.1K
Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
4.1K
Standards of Care II
629
Nurses bear specific legal responsibilities under several federal statutes, including:
629
Clinical Trials
6.6K
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
There are four phases in a clinical trial. A phase one...
6.6K
Clinical Trials: Overview
2.6K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
2.6K
